Population pharmacokinetics and pharmacodynamics of meropenem in Japanese pediatric patients

Journal of Infection and Chemotherapy

Volumn 16, Issue 2, 2010, Pages 139-143

  Ikawa, Kazuro ^a   Morikawa, Norifumi ^a   Ikeda, Kayo ^a   Miki, Mizuka ^a   Kobayashi, Masao ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Child; Meropenem; Monte Carlo simulation; Pharmacokinetics pharmacodynamics (PK PD); Population pharmacokinetics

Indexed keywords

MEROPENEM;

ADOLESCENT; ARTICLE; BACTERICIDAL ACTIVITY; BODY WEIGHT; CHILD; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; ESCHERICHIA COLI; HAEMOPHILUS MENINGITIS; HUMAN; JAPANESE; KIDNEY CLEARANCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; PLASMA; POPULATION; PRESCHOOL CHILD; PROBABILITY; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SIMULATION; STREPTOCOCCUS PNEUMONIAE; URINE;

EID: 77952236737     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0025-0     Document Type: Article

References (18)

1. JJ Perez-Ruixo P Zannikos S Hirankarn K Stuyckens EA Ludwig A Soto-Matos, et al. 2007 Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients Clin Pharmacokinet 46 867 884 10.2165/00003088- 200746100-00005 1:CAS:528:DC%2BD2sXht1yktr%2FJ 17854236 (Pubitemid 47443311)
2. PL Chan B Weatherley L McFadyen 2008 A population pharmacokinetic meta-analysis of maraviroc in healthy volunteers and asymptomatic HIV-infected subjects Br J Clin Pharmacol 65 Suppl 1 76 85 10.1111/j.1365-2125.2008.03139.x 1:CAS:528:DC%2BD1cXlt1CgtL8%3D 18333869 (Pubitemid 351366542)
3. DP Nicolau 2008 Pharmacokinetic and pharmacodynamic properties of meropenem Clin Infect Dis 47 Suppl 1 S32 S40 10.1086/590064 1:CAS:528: DC%2BD1cXhtFyhtb7N 18713048
4. K Fujita K Murono M Saijyo H Yoshioka S Maruyama H Sakata, et al. 1992 Clinical and pharmacokinetic evaluation of meropenem and its effect on fecal flora in children Jpn J Antibiot 45 718 726 1:STN:280:DyaK38zntl2mtQ%3D%3D 1507402
5. H Tsutsumi S Chiba 1992 Clinical pharmacology and efficacy of meropenem Jpn J Antibiot 45 727 733 1:CAS:528:DyaK38Xlt1eqtr0%3D 1507403
6. T Tajima S Negishi Y Kondo S Nishimura A Higa N Hagiwara, et al. 1992 Pharmacokinetic, bacteriological and clinical studies on meropenem in children Jpn J Antibiot 45 826 832 1:STN:280:DyaK38zpsFOmuw%3D%3D 1522674
7. K Niinou H Sato S Nakazawa 1992 Studies of meropenem in pediatric infections Jpn J Antibiot 45 833 844 1:STN:280:DyaK38zpsFOlsg%3D%3D 1522675
8. Y Toyonaga K Yamori K Hatakeyama T Ishihara K Kawamura K Seo, et al. 1992 Pharmacokinetic and clinical studies on meropenem Jpn J Antibiot 45 850 865 1:STN:280:DyaK38zpsFOlsA%3D%3D 1522677
9. H Meguro A Mori R Fujii I Terashima T Kurosaki T Toba, et al. 1992 Clinical evaluation of a new carbapenem, meropenem, in infants and children Jpn J Antibiot 45 866 879 1:STN:280:DyaK38zpsFOlsQ%3D%3D 1522678
10. K Kuno A Ogawa F Hayakawa H Takeuchi K Ito Y Takimoto, et al. 1992 Laboratory and clinical studies on meropenem in pediatrics Jpn J Antibiot 45 880 888 1:STN:280:DyaK38zpsFOltg%3D%3D 1522679
11. T Haruta S Kuroki K Okura H Nikami T Nishio Y Kobayashi 1992 Studies on meropenem in the field of pediatrics Jpn J Antibiot 45 897 904 1:STN:280:DyaK38zpsFOltA%3D%3D 1522681
12. K Ikeda K Ikawa N Morikawa M Miki S Nishimura M Kobayashi 2007 High-performance liquid chromatography with ultraviolet detection for real-time therapeutic drug monitoring of meropenem in plasma J Chromatogr B Analyt Technol Biomed Life Sci 856 371 375 10.1016/j.jchromb.2007.05.043 1:CAS:528: DC%2BD2sXpvFKgu7w%3D 17581801 (Pubitemid 47302913)
13. K Ikawa N Morikawa S Uehara K Monden Y Yamada N Honda, et al. 2009 Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients Int J Antimicrob Agents 33 276 279 10.1016/j.ijantimicag.2008. 08.031 1:CAS:528:DC%2BD1MXit1Kkt74%3D 19095418
14. 14C]meropenem in dogs and monkeys Jpn J Chemother 40 Suppl 1 145 153 1:CAS:528:DyaK38XktF2rtr4%3D
15. K Kanazawa Y Ueda 2004 In vitro antimicrobial activity of meropenem against clinical isolates of various bacterial species from pediatric patients in Japan Jpn J Chemother 52 1 16 1:CAS:528:DC%2BD2cXhslWrt70%3D (Pubitemid 38208432)
16. EM Parker M Hutchison JL Blumer 1995 The pharmacokinetics of meropenem in infants and children: a population analysis J Antimicrob Chemother 36 Suppl A 63 71 1:CAS:528:DyaK2MXnvFanu7o%3D 8543500
17. X Du C Li JL Kuti CH Nightingale DP Nicolau 2006 Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients J Clin Pharmacol 46 69 75 10.1177/0091270005283283 1:CAS:528:DC%2BD28Xot1Gjsw%3D%3D 16397286 (Pubitemid 43021715)
18. K Ikawa N Morikawa K Ikeda H Ohge T Sueda 2008 Development of breakpoints of carbapenems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in peritoneal fluid J Infect Chemother 14 330 332 10.1007/s10156-008-0624-1 1:CAS:528:DC%2BD1cXhtVSku7jJ 18709540